Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers

Bibliographic Details
Main Authors:	John Anderson, Marta Barisa
Format:	Article
Language:	English
Published:	Elsevier 2023-09-01
Series:	Molecular Therapy: Oncolytics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770523000591

Similar Items

Enhancing the effectiveness of γδ T cells by mRNA transfection of chimeric antigen receptors or bispecific T cell engagers
by: Scott A. Becker, et al.
Published: (2023-06-01)

Bispecific T-Cell Engagers and Chimeric Antigen Receptor T-Cell Therapies in Glioblastoma: An Update
by: Roa Alsajjan, et al.
Published: (2023-09-01)

Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
by: Artemis Gavriil, et al.
Published: (2020-08-01)

Novel Lipid Nanoparticles Stable and Efficient for mRNA Transfection to Antigen-Presenting Cells
by: Kang Chan Choi, et al.
Published: (2024-01-01)

Bispecific Chimeric Antigen Receptor T Cell Therapy for B Cell Malignancies and Multiple Myeloma
by: Robert J. Cronk, et al.
Published: (2020-09-01)

mRNA‐based chimeric antigen receptor T cell therapy: Basic principles, recent advances and future directions
by: Kaiting Xiao, et al.
Published: (2024-01-01)

Immortalized B Cells Transfected with mRNA of Antigen Fused to MITD (IBMAM): An Effective Tool for Antigen-Specific T-Cell Expansion and TCR Validation
by: Zhe Wang, et al.
Published: (2023-03-01)

In Vitro-Transcribed mRNA Chimeric Antigen Receptor T Cell (IVT mRNA CAR T) Therapy in Hematologic and Solid Tumor Management: A Preclinical Update
by: Thangavelu Soundara Rajan, et al.
Published: (2020-09-01)

T Cell Engaging Immunotherapies, Highlighting Chimeric Antigen Receptor (CAR) T Cell Therapy
by: Elien De Bousser, et al.
Published: (2021-12-01)

Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
by: Justin C. Boucher, et al.
Published: (2023-12-01)

Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management
by: Mariam Markouli, et al.
Published: (2023-07-01)

Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors
by: Julia Hambach, et al.
Published: (2022-11-01)

Resveratrol Enhances mRNA and siRNA Lipid Nanoparticles Primary CLL Cell Transfection
by: Edo Kon, et al.
Published: (2020-06-01)

METTL3-mediated m6A methylation orchestrates mRNA stability and dsRNA contents to equilibrate γδ T1 and γδ T17 cells
by: Zhiqiang Xiao, et al.
Published: (2023-07-01)

Correlation of Peripheral Chimeric Antigen Receptor T-cell (CAR-T Cell) mRNA Expression Levels with Toxicities and Outcomes in Patients with Diffuse Large B-cell Lymphoma
by: Christian Messerli, et al.
Published: (2023-08-01)

Iron Oxide Nanoparticle-Mediated mRNA Delivery to Hard-to-Transfect Cancer Cells
by: Jianxi Huang, et al.
Published: (2023-07-01)

Chimeric Antigen Receptor-T Cell Therapy
by: Jochen Buechner, et al.
Published: (2018-02-01)

Structure of a fully assembled γδ T-cell antigen receptor
by: Gully, BS, et al.
Published: (2024)

Preclinical platforms to study therapeutic efficacy of human γδT‐cells for oncology indications
by: Marta Barisa, et al.
Published: (2022-06-01)

Editorial: Optimized gene-engineering and combination therapies to boost γδT cell immunotherapeutic performance
by: Marta Barisa, et al.
Published: (2024-04-01)

Differences in the phenotypes and transcriptomic signatures of chimeric antigen receptor T lymphocytes manufactured via electroporation or lentiviral transfection
by: Anna Niu, et al.
Published: (2023-05-01)

Chimeric Antigen Receptor T-Cell Therapy for Glioblastoma
by: Kun Ma, et al.
Published: (2023-11-01)

Chimeric Antigen Receptor beyond CAR-T Cells
by: Vicky Mengfei Qin, et al.
Published: (2021-01-01)

Chimeric Antigen Receptor T-Cell Therapy and Hematopoiesis
by: Bryanna Reinhardt, et al.
Published: (2023-02-01)

Chimeric Antigen Receptor T Cell Therapy in Hematology
by: Pınar Ataca, et al.
Published: (2015-11-01)

Hybrid Biopolymer and Lipid Nanoparticles with Improved Transfection Efficacy for mRNA
by: Christian D. Siewert, et al.
Published: (2020-09-01)

mRNA Lipoplexes with Cationic and Ionizable α-Amino-lipophosphonates: Membrane Fusion, Transfection, mRNA Translation and Conformation
by: Sohail Akhter, et al.
Published: (2022-03-01)

mRNA as a Tool for Gene Transfection in 3D Cell Culture for Future Regenerative Therapy
by: Satoshi Uchida, et al.
Published: (2020-04-01)

T cells expressing CD5/CD7 bispecific chimeric antigen receptors with fully human heavy-chain-only domains mitigate tumor antigen escape
by: Zhenyu Dai, et al.
Published: (2022-03-01)

Chimeric Antigen Receptor T Cell and Chimeric Antigen Receptor NK Cell Therapy in Pediatric and Adult High-Grade Glioma—Recent Advances
by: Adrian Kowalczyk, et al.
Published: (2024-01-01)

LINE1-Mediated Reverse Transcription and Genomic Integration of SARS-CoV-2 mRNA Detected in Virus-Infected but Not in Viral mRNA-Transfected Cells
by: Liguo Zhang, et al.
Published: (2023-02-01)

LINE1-Mediated Reverse Transcription and Genomic Integration of SARS-CoV-2 mRNA Detected in Virus-Infected but Not in Viral mRNA-Transfected Cells
by: Zhang, Liguo, et al.
Published: (2023)

pH-Responsive Lipid Nanoparticles Achieve Efficient mRNA Transfection in Brain Capillary Endothelial Cells
by: Yu Sakurai, et al.
Published: (2022-07-01)

Supercharged chimeric antigen receptor T cells in solid tumors
by: Ayush Pant, et al.
Published: (2022-08-01)

Chimeric antigen receptor‐T cell therapies: The changing landscape
by: Salyka M. Sengsayadeth, et al.
Published: (2022-01-01)

Chimeric antigen receptor T-cell therapy for multiple myeloma
by: Zehua Wang, et al.
Published: (2022-12-01)

Chimeric antigen receptor T cells applied to solid tumors
by: Zhongguo Zhou, et al.
Published: (2022-10-01)

Chimeric antigen receptor T-cell therapy for T-ALL and AML
by: Wenwen Wei, et al.
Published: (2022-11-01)

Chimeric antigen receptor modified T-cells for cancer treatment
by: Xiao Han, et al.
Published: (2018-12-01)

Telemedicine in Hematopoietic Cell Transplantation and Chimeric Antigen Receptor-T Cell Therapy
by: Arpita P. Gandhi, et al.
Published: (2023-08-01)